Skip Nav Destination
Abstract B176: Results of a phase I study of PLX8394, a next-generation BRAF inhibitor, in refractory solid tumors
Mol Cancer Ther (2018) 17 (1_Supplement): B176.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Rona Yaeger
- Meredith A. McKean
- Rizwan Haq
- J. Thaddeus Beck
- Matthew H. Taylor
- Jonathan E. Cohen
- Daniel W. Bowles
- Shirish M. Gadgeel
- Catalin Mihalcioiu
- Kyriakos P. Papadopoulos
- Eli L. Diamond
- Keren B. Sturtz
- Gang Feng
- Stefanie K. Drescher
- Micaela B. Reddy
- Bhaswati Sengupta
- Arnab K. Maity
- Suzy A. Brown
- Anurag Singh
- Eric N. Brown
- Brian R. Baer
- Jim Wong
- Tung-Chung Mou
- Wen-I Wu
- Dean R. Kahn
- Sunyana Gadal
- Neal Rosen
- John J. Gaudino
- Patrice A. Lee
- Dylan P. Hartley
- S. Michael Rothenberg
Cancer Discovery (2024) 14 (9): 1599.
- Ibrahim Halil Sahin
- Jim Klostergaard
JCO Oncology Practice (2021) 17 (12): 723.
- Philip Klövekorn
- Bent Pfaffenrot
- Michael Juchum
- Roland Selig
- Wolfgang Albrecht
- Lars Zender
- Stefan A. Laufer
European Journal of Medicinal Chemistry (2021) 210: 112963.
- Maria Diab
JCO Oncology Practice (2021) 17 (12): 731.
RSS Feeds